UCL Live


UCL-TB and the TB Centre at The London School of Hygiene & Tropical Medicine (LSHTM) are marking World TB Day 2015 with an all-day event on Tuesday 24 March.

Join the conversation on Twitter: #WorldTBDay @UCLSLMS and @LSHTM_TB

Title: World TB Day 2015: What do we need to know to reach, treat and cure everyone with TB?
Dates: Tuesday, 24th March 2015
Times: 09:15 - 16:30 (GMT)
Location: Kennedy Lecture Theatre, UCL Institute of Child Health, 30 Guilford Street, London. WC1N 1EH.
More details: http://events.ucl.ac.uk/event/event:l6k-i56ldg6e-pc6cp5


World TB Day 2015: What do we need to know to reach, treat and cure everyone with TB?

Eminent national and international speakers will highlight the leading issues and research to reach, treat and cure those with tuberculosis, including a debate about the management of multidrug-resistant TB contacts. The meeting will also review the new Public Health England (PHE) and NHS England collaborative five year TB national strategy to eliminate TB as its implementation begins.

Through bringing a wide range of researchers together we aim to encourage new cross-disciplinary links and collaborations between scientists and clinicians at the forefront of the TB field.

09:15–09:30 Welcome and introductions

  • Professor Ibrahim Abubakar (Professor of Infectious Disease Epidemiology, MRC Clinical Trials Unit at UCL, and Director, Centre for Infectious Disease Epidemiology)
  • Dr Helen Fletcher (PhD, Senior Lecturer in Immunology, LSHTM)

09:30–10:30 Session 1: Plenary lectures/Scene setting

  • Chair: Dr Helen Fletcher (as above)
  • Professor Anne O'Gara (Head of Division of Immunoregulation, MRC National Institute for Medical Research (NIMR) and Chair of Infection Immunology, Faculty of Medicine, Imperial College London): Where are we now? Where should we go? The science of TB
  • Dr Stephen D. Lawn (Reader in Infectious Diseases & Tropical Medicine, LSHTM): Can antiretroviral therapy control the HIV-associated TB epidemic?

10:3011:00 Networking break

11:00–12:00 Session 2: Global strategy

  • Chair: Professor Timothy McHugh (Director, Centre for Clinical Microbiology at UCL)
  • Dr Mukund Uplekar (Senior Medical Officer, Policy, Strategy and Innovations Unit, Global TB Programme, World Health Organization (WHO)): WHO’s global TB strategy post-2015
  • Professor Eskild Petersen (Editor-in-Chief, IJID Journal and Professor of Tropical Medicine and Parasitology Senior Consultant Department of Infectious Diseases Aarhus University Hospital Skejby Aarhus Denmark): Overview of the IJID TB Journal Series
  • Dr Ruth McNerney: New TB diagnostics and rollout
  • Dr Katherine Fielding (Reader in Medical Statistics & Epidemiology, LSHTM): Treatment adherence and m-health in China

12:0012:50 Lunch

12:50–13:35 Session 3: Debate - Tools vs Social Determinants

  • Chair: Dr Marc Lipman (Senior Clinical Lecturer (Honorary Consultant), UCL Division of Medicine)
  • Dr Delia Boccia (Lecturer Social Epidemiology, LSHTM)
  • Professor Andrew Hayward (Professor of Infectious Disease Epidemiology and Inclusion Health Research, UCL Institute of Epidemiology & Health Care)

13:35–14:45 Session 4: National Strategy

  • Chair: Dr Helen Booth (Consultant Thoracic Physician, UCLH, Clinical Lead, Integrated TB NCL-Service)
  • Duncan Selbie (Chief Executive, Public Health England): Overview of  the collaborative TB Strategy for England 2015-2020
  • Dr Kunst Heinke (Senior Lecturer, Barts Health NHS Trust): Critique of the collaborative TB Strategy for England 2015-20120
  • Professor Graham Bothamley (Honorary Professor, QMUL, Chair of TB for the European Respiratory Society, Chair of TB Network European Trialsgroup (TBnet)): Research implications of the collaborative TB Strategy for England 2015-2020
  • Aaron Oxley (Executive Director, RESULTS UK): Advocacy implications of the collaborative TB Strategy for England 2015-2020

14:4515:15 Networking break

15:15–16:15 Session 5: Clinical trials

  • Chair: Professor Andrew Nunn (Scientific Programme Leader, Medical Research Council Clinical Trials Unit at UCL)
  • Dr James Seddon (Clinical Lecturer, Section of Paediatrics, Department of Medicine, Imperial College London): Multidrug-resistant tuberculosis in children
  • Dr Bern-Thomas Nyang'wa (Project Manager & Chief Investigator, TB-PRACTECAL Project, Manson Unit, Médecins Sans Frontières/Doctors Without Borders (MSF)): Phase 3 MDR-TB clinical trials: Lessons from 'quinolones for TB studies'
  • Professor Francois Balloux (Professor of Computational Systems Biology, UCL Genetics Institute, Department of Genetics, Evolution and Environment): Data on NGS directly on spectrum for detecting TB drug restistances

16:15–16:30 Concluding remarks

  • Professor David Moore (Professor of Infectious Diseases & Tropical Medicine, LSHTM)
  • Professor Timothy McHugh (as above)

16:30–17:30 Networking reception

Experiencing problems?  View our frequently asked questions

Are you experiencing any problems viewing the UCL Live webcasts? If so, please select this link to visit the live webcasting Frequently Asked Questions (FAQs).